BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21410269)

  • 21. Proteomic analysis of laser capture microdissected focal lesions in a rat model of progenitor marker-positive hepatocellular carcinoma.
    Adebayo Michael AO; Ahsan N; Zabala V; Francois-Vaughan H; Post S; Brilliant KE; Salomon AR; Sanders JA; Gruppuso PA
    Oncotarget; 2017 Apr; 8(16):26041-26056. PubMed ID: 28199961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
    Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H
    Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
    Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
    Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Missing Proteins Using the PRIDE Database as a Source of Mass Spectrometry Evidence.
    Garin-Muga A; Odriozola L; Martínez-Val A; Del Toro N; Martínez R; Molina M; Cantero L; Rivera R; Garrido N; Dominguez F; Sanchez Del Pino MM; Vizcaíno JA; Corrales FJ; Segura V
    J Proteome Res; 2016 Nov; 15(11):4101-4115. PubMed ID: 27581094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 27. Generation of a predicted protein database from EST data and application to iTRAQ analyses in grape (Vitis vinifera cv. Cabernet Sauvignon) berries at ripening initiation.
    Lücker J; Laszczak M; Smith D; Lund ST
    BMC Genomics; 2009 Jan; 10():50. PubMed ID: 19171055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    Chandrashekar DS; Golonka RM; Yeoh BS; Gonzalez DJ; Heikenwälder M; Gerwirtz AT; Varambally S; Vijay-Kumar M
    PLoS One; 2020; 15(6):e0234726. PubMed ID: 32559205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry.
    Reiter L; Claassen M; Schrimpf SP; Jovanovic M; Schmidt A; Buhmann JM; Hengartner MO; Aebersold R
    Mol Cell Proteomics; 2009 Nov; 8(11):2405-17. PubMed ID: 19608599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.
    Zhang J; Liang R; Wei J; Ye J; He Q; ChunlingYuan ; Ye J; Li Y; Liu Z; Lin Y
    Biomed Res Int; 2018; 2018():5484976. PubMed ID: 30345303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.
    Long X; Zhang J; Zhang Y; Yao J; Cai Z; Yang P
    Mol Biosyst; 2011 May; 7(5):1728-41. PubMed ID: 21423987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.
    Yang L; Rong W; Xiao T; Zhang Y; Xu B; Liu Y; Wang L; Wu F; Qi J; Zhao X; Wang H; Han N; Guo S; Wu J; Gao Y; Cheng S
    Sci China Life Sci; 2013 Jul; 56(7):638-46. PubMed ID: 23749381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression.
    Ranjpour M; Wajid S; Jain SK
    Anticancer Agents Med Chem; 2019; 19(2):236-247. PubMed ID: 30324893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mining gene functional networks to improve mass-spectrometry-based protein identification.
    Ramakrishnan SR; Vogel C; Kwon T; Penalva LO; Marcotte EM; Miranker DP
    Bioinformatics; 2009 Nov; 25(22):2955-61. PubMed ID: 19633097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
    Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
    Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
    Zhang J; Lu S; Zhou Y; Meng K; Chen Z; Cui Y; Shi Y; Wang T; He QY
    Proteomics; 2017 Jul; 17(13-14):. PubMed ID: 28590090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.